Literature DB >> 15501584

Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways.

Denis Nonclercq1, Fabrice Journé, Jean-Jacques Body, Guy Leclercq, Guy Laurent.   

Abstract

Molecular chaperones and co-chaperones, such as heat-shock proteins (Hsp's), play a pivotal role in the adequate folding and the stability of steroid hormone receptors. As shown by immunofluorescence staining and immunoblot analysis, the Hsp90 inhibitor radicicol induced a rapid (within hours) depletion of estrogen receptor-alpha (ER) in MCF-7 and IBEP-2 breast carcinoma cells. Inhibition of proteasomes (MG-132, LLnL) or of protein synthesis (cycloheximide), which both suppressed E(2)-induced downregulation of ER, failed to modify ER degradation caused by radicicol. On the other hand, partial antiestrogens, such as hydroxytamoxifen (a triphenylethylene) and LY 117,018 (a benzothiophene) stabilized ER, making it immune to radicicol-induced degradation. Furthermore, radicicol did not interfere with ER upregulation induced by hydroxytamoxifen. Thus, the current study points to possible variation in the mechanism/pathway of ER breakdown. Besides, the protective effect of partial antiestrogens suggests that ER stability is only compromized by Hsp90 disruption when the receptor is in its native, unliganded form.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501584     DOI: 10.1016/j.mce.2004.07.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

1.  Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.

Authors:  Piergiorgio La Rosa; Valeria Pesiri; Guy Leclercq; Maria Marino; Filippo Acconcia
Journal:  Mol Endocrinol       Date:  2012-03-22

2.  The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription.

Authors:  Hua Zhang; Luyang Sun; Jing Liang; Wenhua Yu; Ying Zhang; Yan Wang; Yupeng Chen; Ruifang Li; Xiaojing Sun; Yongfeng Shang
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

3.  Toward functional glycomics by localization of tissue lectins: immunohistochemical galectin fingerprinting during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.

Authors:  Sven Saussez; Denis Nonclercq; Guy Laurent; Rudy Wattiez; Sabine André; Herbert Kaltner; Hans-Joachim Gabius; Robert Kiss; Gérard Toubeau
Journal:  Histochem Cell Biol       Date:  2004-12-18       Impact factor: 4.304

Review 4.  The different roles of ER subtypes in cancer biology and therapy.

Authors:  Christoforos Thomas; Jan-Åke Gustafsson
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

5.  Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.

Authors:  Natalia Vydra; Patryk Janus; Paweł Kus; Tomasz Stokowy; Katarzyna Mrowiec; Agnieszka Toma-Jonik; Aleksandra Krzywon; Alexander Jorge Cortez; Bartosz Wojtas; Bartłomiej Gielniewski; Roman Jaksik; Marek Kimmel; Wieslawa Widlak
Journal:  Elife       Date:  2021-11-16       Impact factor: 8.140

6.  Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.

Authors:  Nicholas B Berry; Meiyun Fan; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2008-04-03

Review 7.  Genotype-guided tamoxifen therapy: time to pause for reflection?

Authors:  Timothy L Lash; Ernst A Lien; Henrik Toft Sørensen; Stephen Hamilton-Dutoit
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

8.  Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.

Authors:  Amanda Cañas; Laura M López-Sánchez; Araceli Valverde-Estepa; Vanessa Hernández; Elena Fuentes; Juan R Muñoz-Castañeda; Chary López-Pedrera; Juan R De La Haba-Rodríguez; Enrique Aranda; Antonio Rodríguez-Ariza
Journal:  Breast Cancer Res       Date:  2012-12-05       Impact factor: 6.466

9.  Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms.

Authors:  Songyin Huang; Yang Chen; Zhi-Mei Liang; Na-Na Li; Yujie Liu; Yinghua Zhu; Dingzhun Liao; Xiao Zhen Zhou; Kun Ping Lu; Yandan Yao; Man-Li Luo
Journal:  Front Cell Dev Biol       Date:  2019-12-06

10.  RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells.

Authors:  Jun Sun; Gabriel Gaidosh; Ye Xu; Adnan Mookhtiar; Na Man; Pradeep Reddy Cingaram; Ezra Blumenthal; Ramin Shiekhattar; Erik T Goka; Stephen D Nimer; Marc E Lippman
Journal:  Oncogene       Date:  2021-08-09       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.